Humacyte plans to file a supplemental Biologic License Application (BLA) with the Food and Drug Administration (FDA) during the second half of ...

Please provide your email address to receive an email when new articles are posted on . The type of arteriovenous access placement, graft or fistula, used first in older patients receiving ...

Please provide your email address to receive an email when new articles are posted on . For older patients who initiated hemodialysis without permanent access, those with arteriovenous fistula ...

The Society of Interventional Radiology (SIR) published new practice guidance for the creation of percutaneous arteriovenous fistulas (pAVFs) for dialysis access. The guidance was published online in ...

SAN DIEGO—Arteriovenous (AV) fistula patency rates, even after intervention with angioplasty, do not differ between younger and older hemodialysis patients, according to new data presented here at the ...

Selecting the most effective hemodialysis access method is arguably the most crucial decision in managing end-stage renal disease. Two of the most widely used surgical options are the Cimino ...